Stoke Therapeutics, Inc. (STOK)
30.47
-2.53
(-7.67%)
USD |
NASDAQ |
Dec 09, 16:00
31.80
+1.33
(+4.36%)
Pre-Market: 08:24
Stoke Therapeutics Profit Margin (Quarterly): -360.7% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 19.00% |
| Janux Therapeutics, Inc. | -243.1% |
| Insmed, Inc. | -260.0% |
| Sarepta Therapeutics, Inc. | -45.06% |
| Aldeyra Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.95% |
| Return on Assets | 11.82% |
| Return on Invested Capital | 13.73% |
| Gross Profit Margin (Quarterly) | 90.70% |
| Operating Margin (Quarterly) | -405.3% |
| Return on Net Operating Assets | 197.6% |